BBNX INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Beta Bionics, Inc. Shareholders

Kirby McInerney LLP is alerting Beta Bionics investors about a securities fraud class action lawsuit covering the period July 30, 2025 through February 24, 2026. The lawsuit alleges the company made false statements regarding its iLet insulin pump, which was malfunctioning and dosing patients with dangerously high insulin levels. The FDA issued a Form 483 and later a warning letter citing quality management failures and lack of corrective action. The stock declined significantly following earnings misses and FDA disclosures in January and February 2026.